Acute Treatment of Stroke (Except Thrombectomy)
Purpose of Review
The management of patients with acute stroke has been revolutionized in recent years with the advent of new effective treatments. In this rapidly evolving field, we provide an update on the management of acute stroke excluding thrombectomy, looking to recent, ongoing, and future trials.
Large definitive trials have provided insight into acute stroke care including broadening the therapeutic window for thrombolysis, alternatives to standard dose alteplase, the use of dual antiplatelet therapy early after minor ischemic stroke, and treating elevated blood pressure in intracerebral hemorrhage. Further ongoing and future trials are eagerly awaited in this ever-expanding area.
Although definitive trials have led to improvements in acute stroke care, there remains a need for further research to improve our understanding of pathophysiological mechanisms underlying different stroke types with the potential for treatments to be tailored to the individual.
KeywordsAcute ischemic stroke Intracerebral hemorrhage Thrombolysis Antiplatelets Blood pressure Stroke unit
Compliance with Ethical Standards
Conflict of Interest
Dr. Anderson reports grants from the National Health and Medical Research Council (NHMRC) of Australia, personal fees from Amgen, grants from Takeda China, and personal fees from Takeda China, outside the submitted work. Dr. Bath reports personal fees from Nestle, non-financial support and other from Platelet Solutions, personal fees and other from DiaMedica, and personal fees from Phagenesis, outside the submitted work. Dr. Muñoz Venturelli reports grants from FONDECYT Regular 2018, grants from Clínica Alemana de Santiago, and grants from The George Institute for Global Health, during the conduct of the study.
Dr. Appleton declares no potential conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 1.Mackay J, Mensah G. The atlas of heart disease and stroke. WHO library 2004. Available from: http://www.Who.Int/cardiovascular_diseases/resources/atlas/en/.
- 14.•• Thomalla G, Simonsen CZ, Boutitie F, Andersen G, Berthezene Y, Cheng B, et al. MRI-guided thrombolysis for stroke with unknown time of onset. N Engl J Med. 2018. WAKE-UP trial: Alteplase vs. normal saline in those with stroke of unknown time of onset with MRI diffusion-FLAIR mismatch was associated with improved 90 day functional outcome. Google Scholar
- 16.• Anderson CS, Robinson T, Lindley RI, Arima H, Lavados PM, Lee TH, et al. Low-dose versus standard-dose intravenous alteplase in acute ischemic stroke. N Engl J Med. 2016;374:2313–23. ENCHANTED trial: low-dose vs. standard-dose alteplase failed to show non-inferiority, but those on antiplatelet agents pre-stroke may benefit from low-dose. CrossRefGoogle Scholar
- 17.Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2018;49:e46–e110.CrossRefGoogle Scholar
- 18.Hacke W, Furlan AJ, Al-Rawi Y, Davalos A, Fiebach JB, Gruber F, et al. Intravenous desmoteplase in patients with acute ischaemic stroke selected by mri perfusion-diffusion weighted imaging or perfusion ct (dias-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol. 2009;8:141–50.CrossRefGoogle Scholar
- 24.•• Campbell BCV, Mitchell PJ, Churilov L, Yassi N, Kleinig TJ, Dowling RJ, et al. Tenecteplase versus alteplase before thrombectomy for ischemic stroke. N Engl J Med. 2018;378:1573–82. EXTEND-IA TNK trial: TNK vs. alteplase in large vessel occlusion pre-thrombectomy. TNK reduced the need for thrombectomy and improved 90 day functional outcome without increasing sICH. CrossRefGoogle Scholar
- 25.Ciccone A, Motto C, Abraha I, Cozzolino F, Santilli I. Glycoprotein IIb-IIIa inhibitors for acute ischaemic stroke. Cochrane Database Syst Rev. 2014;204(3):CD005208.Google Scholar
- 27.Adeoye O, Sucharew H, Khoury J, Tomsick T, Khatri P, Palesch Y, et al. Recombinant tissue-type plasminogen activator plus eptifibatide versus recombinant tissue-type plasminogen activator alone in acute ischemic stroke: propensity score-matched post hoc analysis. Stroke. 2015;46:461–4.CrossRefGoogle Scholar
- 30.Stroke Unit Trialists C. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev. 2013;9:CD000197.Google Scholar
- 41.Rothwell PM, Giles MF, Chandratheva A, Marquardt L, Geraghty O, Redgrave JN, et al. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (express study): a prospective population-based sequential comparison. Lancet. 2007;370:1432–42.CrossRefGoogle Scholar
- 46.•• Johnston SC, Easton JD, Farrant M, Barsan W, Conwit RA, Elm JJ, et al. Clopidogrel and aspirin in acute ischemic stroke and high-risk tia. N Engl J Med. 2018;379:215–25. POINT trial: aspirin and clopidogrel vs. aspirin within 12 hours of minor stroke or TIA was associated with reduced major ischemic events but increased major bleeding at 90 days. CrossRefGoogle Scholar
- 48.Amarenco P, Albers GW, Denison H, Easton JD, Evans SR, Held P, et al. Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of socrates, a randomised, double-blind, controlled trial. Lancet Neurol. 2017;16:301–10.CrossRefGoogle Scholar
- 49.• Bath PM, Woodhouse LJ, Appleton JP, Beridze M, Christensen H, Dineen RA, et al. Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (tardis): a randomised, open-label, phase 3 superiority trial. Lancet. 2018;391:850–9. TARDIS trial: triple antiplatelet therapy vs. guideline therapy with 24 hours of AIS or TIA did not reduce stroke recurrence but did cause more, and more severe bleeding. CrossRefGoogle Scholar
- 52.Brunser AM, Muñoz Venturelli P, Lavados PM, Gaete J, Martins S, Arima H, et al. Head position and cerebral blood flow in acute ischemic stroke patients: protocol for the pilot phase, cluster randomized, head position in acute ischemic stroke trial (headpost pilot). Int J Stroke. 2016;11:253–9.CrossRefGoogle Scholar
- 53.Olavarría VV, Brunser A, Munoz Venturelli P, Arima H, Gonzalez F, Gaete J, et al. Head position in stroke trial (headpost) pilot phase results. Euro Stroke J. 2016;1:3–612.Google Scholar
- 54.• Anderson CS, Arima H, Lavados P, Billot L, Hackett ML, Olavarría VV, et al. Cluster-randomized, crossover trial of head positioning in acute stroke. N Engl J Med. 2017;376:2437–47. HEADPOST trial: lying flat vs. elevated head positioning in acute stroke did not influence 90 day functional outcome. CrossRefGoogle Scholar
- 63.•• Qureshi AI, Palesch YY, Barsan WG, Hanley DF, Hsu CY, Martin RL, et al. Intensive blood-pressure lowering in patients with acute cerebral hemorrhage. N Engl J Med. 2016;375:1033–43. ATACH-II trial: intensive vs. standard BP lowering within 4.5hrs of ICH onset did not influence functional outcome at 90 days for reasons discussed above. CrossRefGoogle Scholar
- 66.Royal College of Physicians. National clinical guideline for stroke. Prepared by the intercollegiate stroke working party. 2016.Google Scholar
- 67.Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APHA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Hypertension. 2018;71:1269–324.CrossRefGoogle Scholar
- 69.Huang Y, Sharma V, Robinson T, Lindley R, Chen X, Kim J, et al. Rationale, design, and progress of the enhanced control of hypertension andthrombolysis stroke study (enchanted) trial: an international multicenter 2 × 2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-pa andearly intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment. Int J Stroke. 2015;10:778–88.CrossRefGoogle Scholar
- 71.Woodhouse L, Scutt P, Krishnan K, Berge E, Gommans J, Ntaios G, et al. Effect of hyperacute administration (within 6 hours) of transdermal glyceryl trinitrate, a nitric oxide donor, on outcome after stroke: subgroup analysis of the efficacy of nitric oxide in stroke (ENOS) trial. Stroke. 2015;46:3194–201.CrossRefGoogle Scholar
- 72.Ankolekar S, Fuller M, Cross I, Renton C, Cox P, Sprigg N, et al. Feasibility of an ambulance-based stroke trial, and safety of glyceryl trinitrate in ultra-acute stroke: the rapid intervention with glyceryl trinitrate in hypertensive stroke trial (right, isrctn66434824). Stroke. 2013;44:3120–8.CrossRefGoogle Scholar
- 73.Appleton JP, Scutt P, Dixon M, Howard H, Haywood L, Havard D, et al. Ambulance-delivered transdermal glyceryl trinitrate versus sham for ultra-acute stroke: rationale, design and protocol for the rapid intervention with glyceryl trinitrate in hypertensive stroke trial-2 (RIGHT-2) trial (isrctn26986053). Int J Stroke 2017;0:1–16. 1747493017724627.Google Scholar
- 77.• Roffe C, Nevatte T, Sim J, Bishop J, Ives N, Ferdinand P, et al. Effect of routine low-dose oxygen supplementation on death and disability in adults with acute stroke: the stroke oxygen study randomized clinical trial. JAMA. 2017;318:1125–35. SOS trial: three days of prophylactic low-dose oxygen therapy did not influence functional outcome at 90 days. CrossRefGoogle Scholar
- 78.Stroke Alliance for Europe. Proof trial. 2018;2018. https://www.safestroke.eu/proof (accessed 15 August 2018).
- 80.Bereczki D, Liu M, Fernandes do Prado G, Fekete I. Mannitol for acute stroke. Cochrane Database Syst Rev. 2007. 2007;(3):CD001153Google Scholar
- 83.Sandercock PAG, Counsell C, Kane EJ. Anticoagulants for acute ischaemic stroke. Cochrane Database Syst Rev. 2015;(3):CD000024Google Scholar